🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. Pioglitazone then Placebo

    Takeda

    Diabetes

    approved small molecule completed

    1 trial

  2. Placebo

    Takeda

    Chronic Insomnia

    approved small molecule terminated

    1 trial

  3. Placebo

    Takeda

    Post-Traumatic Stress Disorder

    approved small molecule completed

    1 trial

  4. Prednisone

    Takeda

    Crohn's Disease

    approved small molecule terminated

    1 trial

  5. Prothrombin complex concentrate (coagulation factors IX, II, VII and X in combination)

    Takeda

    Prothrombin Complex Factor Deficiency

    approved mab completed

    1 trial

  6. REPLAGAL

    Takeda

    Fabry Disease

    approved small molecule active

    5 trials

  7. RINVOQ 45 mg prolonged-release tablets, Placebo to Match Blinded Upadacitinib, Entyvio 300 mg powder for concentrate for solution for infusion

    Takeda

    Chron's Disease

    approved small molecule active

    1 trial

  8. RIXUBIS: On-Demand

    Takeda

    Hemophilia B

    approved mab completed

    1 trial

  9. RYMPHYSIA

    Takeda

    Chronic Obstructive Pulmonary Disease (COPD)

    approved mab terminated

    1 trial

  10. Ramelteon

    Takeda

    Chronic Insomnia

    approved small molecule completed

    7 trials

  11. Ramelteon

    Takeda

    Circadian Dysregulation

    approved small molecule completed

    1 trial

  12. Ramelteon

    Takeda

    Schizophrenia

    approved small molecule completed

    1 trial

  13. Ramelteon

    Takeda

    ADHD With Sleep Onset Insomnia

    approved small molecule completed

    1 trial

  14. Ramelteon

    Takeda

    Bipolar Disorder

    approved small molecule terminated

    2 trials

  15. Ramelteon

    Takeda

    Insomnia

    approved small molecule completed

    6 trials

  16. Ramelteon

    Takeda

    Seasonal Affective Disorder

    approved small molecule completed

    1 trial

  17. Ramelteon (RozeremR)

    Takeda

    Insomnia

    approved small molecule terminated

    1 trial

  18. Ramelteon and Placebo

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved small molecule completed

    2 trials

  19. Ramelteon and zolpidem

    Takeda

    Chronic Insomnia

    approved small molecule completed

    1 trial

  20. Ramelteon, zolpidem and placebo

    Takeda

    Insomnia

    approved small molecule completed

    1 trial

  21. Recombinant Protein-Free Factor VIII (rAHF-PFM)

    Takeda

    Hemophilia A

    approved small molecule completed

    1 trial

  22. SPD489

    Takeda

    ADHD Specifically With Executive Function Impairment

    approved small molecule completed

    1 trial

  23. SPD489 (Lisdexamfetamine dimesylate)

    Takeda

    Attention-Deficit/Hyperactivity Disorder

    approved small molecule completed

    1 trial

  24. TACHOSIL GROUP

    Takeda

    Lymphocele

    approved mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources